title: Cancer immunotherapy and immunological memory.
abstract: Human immunological memory is the key distinguishing hallmark of the adaptive immune system and plays an important role in the prevention of morbidity and the severity of infection. The differentiation system of T cell memory has been clarified using mouse models. However, the human T cell memory system has great diversity induced by natural antigens derived from many pathogens and tumor cells throughout life, and profoundly differs from the mouse memory system constructed using artificial antigens and transgenic T cells. We believe that only human studies can elucidate the human immune system. The importance of immunological memory in cancer immunotherapy has been pointed out, and the trafficking properties and long-lasting anti-tumor capacity of memory T cells play a crucial role in the control of malignant tumors. Adoptive cell transfer of less differentiated T cells has consistently demonstrated superior anti-tumor capacity relative to more differentiated T cells. Therefore, a human T cell population with the characteristics of stem cell memory is thought to be attractive for peptide vaccination and adoptive cell transfer. A novel human memory T cell population that we have identified is closer to the naive state than previous memory T cells in the T cell differentiation lineage, and has the characteristics of stem-like chemoresistance. Here we introduce this novel population and describe the fundamentals of immunological memory in cancer immunotherapy.
authors.affiliation: Department of Pathology, Sapporo Medical University School of Medicine.
authors.forename: Kenji
authors.initials: K
authors.lastname: Murata
authors.forename: Tomohide
authors.initials: T
authors.lastname: Tsukahara
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Torigoe
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines; D006801:Humans; D007156:Immunologic Memory / Q000276:immunology*; D007167:Immunotherapy; D016219:Immunotherapy, Adoptive; D054503:Lymphoid Progenitor Cells / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000517:prevention & control; D013601:T-Lymphocytes / Q000276:immunology*; D022223:Vaccines, Subunit
chemical_list: D019496:Cancer Vaccines; D022223:Vaccines, Subunit